Marshall S, Fleming A, Moore A C, Sahm L J
School of Pharmacy, University College Cork, Cork, Ireland.
School of Pharmacy, University College Cork, Cork, Ireland; Department of Pharmacy, Mercy University Hospital, Cork, Ireland.
Vaccine. 2017 Sep 5;35(37):4896-4904. doi: 10.1016/j.vaccine.2017.07.083. Epub 2017 Aug 2.
Vaccines incorporated into microneedle-based patch platforms offer advantages over conventional hypodermic injections. However, the success and clinical utility of these platforms will depend on its acceptance among stakeholders. Minimal focus has been placed on determining parents' acceptability of microneedle-patch vaccines intended for paediatric use. This qualitative study probes the perceived acceptability of microneedle technology for paediatric vaccination in a parent population.
Focus groups (n=6) were convened through purposive sampling of Cork city primary schools. Discussions were audio-recorded, transcribed verbatim, anonymised, independently verified and analysed by thematic analysis, with constant comparison method applied throughout.
The opinions of 32 parents were included. All participants declared that their children were fully vaccinated. Five core themes were identified and defined as: (i) concern, (ii) suitability for paediatric use, (iii) potential for parental administration, (iv) the role of the healthcare professional and (v) special populations. Drivers for acceptance include; concerns with current vaccines and vaccination programmes; attributes of microneedle-patch (reduced pain, bleeding, fear and increased convenience) and endorsement by a healthcare professional. Barriers to acceptance include; lack of familiarity, concerns regarding feasibility and suitability in paediatrics, allergic potential, inability to confirm delivery and potential reduction in vaccine coverage.
This is the first study to explore parental acceptance of microneedle-patch vaccines. Capturing the opinions of parents, the ultimate decision makers in paediatric vaccination, is crucial in the understanding of the eventual uptake of microneedle technology and therefore adds to literature currently available. This study has revealed that even "vaccine-acceptors"; parents who agree with, or do not question vaccination, will question the safety and efficacy of this novel method. Participants in this study remained tentative. However, the study has also revealed that endorsement by healthcare professionals could reduce this tentativeness, thereby identifying the role of healthcare professionals in disseminating information and providing support to parents. An increased awareness of developments in microneedle technology is needed to permit informed decision-making by parents.
与传统皮下注射相比,纳入微针贴片平台的疫苗具有诸多优势。然而,这些平台的成功与临床应用将取决于利益相关者对其的接受程度。对于确定家长对儿科用微针贴片疫苗的接受度,目前关注极少。这项定性研究探讨了家长群体对微针技术用于儿科疫苗接种的感知接受度。
通过对科克市小学进行目的抽样召集了6个焦点小组。讨论进行了录音,逐字转录,匿名处理,独立核实并通过主题分析进行分析,在整个过程中应用了持续比较法。
纳入了32位家长的意见。所有参与者均表示其子女已完成全部疫苗接种。确定并定义了五个核心主题:(i)担忧,(ii)儿科适用性,(iii)家长自行接种的可能性,(iv)医护人员的作用,以及(v)特殊人群。接受的驱动因素包括:对现有疫苗和疫苗接种计划的担忧;微针贴片的特性(减轻疼痛、出血、恐惧并增加便利性)以及医护人员的认可。接受的障碍包括:缺乏了解、对儿科可行性和适用性的担忧、过敏可能性、无法确认接种以及疫苗接种覆盖率可能降低。
这是第一项探索家长对微针贴片疫苗接受度的研究。了解家长(儿科疫苗接种的最终决策者)的意见对于理解微针技术的最终采用情况至关重要,因此为现有文献增添了内容。这项研究表明,即使是“疫苗接受者”,即同意或不质疑疫苗接种的家长,也会对这种新方法的安全性和有效性提出质疑。本研究的参与者仍持保留态度。然而,该研究还表明,医护人员的认可可以减少这种保留态度,从而确定了医护人员在传播信息和为家长提供支持方面的作用。需要提高对微针技术发展的认识,以便家长能够做出明智的决策。